Skip to content

Released Oct 20, 2020, before the open

10-Q filed Oct 29, 2020, 29 days after period end · 0001653477-20-000082

Q3 2020 · 10-Q
Revenue$331.70M−7.8% vs Q3 2019+22.6% vs Q2 2020
Net Income$69.90M+16.7% vs Q3 2019+246.0% vs Q2 2020
EPS Diluted$1.69+19.9% vs Q3 2019+244.9% vs Q2 2020
Gross Profit$139,600,000+0.1%
Operating Income$127,600,000+11.9%
Operating Cash Flowderived$90,000,000−24.2%
Free Cash Flowderived$73,500,000−23.9%
Margins · derived
Gross margin42.1%+3.3 pt vs Q3 2019
Operating margin38.5%+6.8 pt vs Q3 2019
Net margin21.1%+4.4 pt vs Q3 2019

What the release said

The release

Same quarter

MetricQ3 2020Q3 2019Q3 2018Q3 2017
Revenue$331.70M$359.90M$311.20M$264.10M
Net Income$69.90M$59.90M$49.50M$33.80M
EPS Diluted$1.69$1.41$1.16$0.79

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ingevity Corp · CIK 1653477 · Engraved from SEC EDGAR